NCT06905262View on ClinicalTrials.gov

Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)

RecruitingOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Hepatocellular Carcinoma

Trial Locations (1)

80131

RECRUITING

Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale, Napoli

All Listed Sponsors

lead

National Cancer Institute, Naples

OTHER